I believe DNAG is not an investment and is, at best, a failing high school science project. They have repeatedly ammended financial reports and misrepresented actual and supposed intended business, changing facts and numbers; regularly participate in toxic financial arrangements that destroy shareholder equity; hires professional stock touters; pays to participate in "conferences"; regularly changes business plans and direction; does not employ cost accounting in any records to date; cannot financially sustain itself and regularly threatens to close the doors if new shares cannot be sold; makes acquisitions and hides abnormal good will expenditures through time; repeated salary bonuses and increases after nonperformance; etc.
Because of repeated fluff news releases the stock can muster ocassional price swings and, to me, can be appealing as a trade vehicle.